Pages that link to "Q33977273"
Jump to navigation
Jump to search
The following pages link to Vitamin C pharmacokinetics: implications for oral and intravenous use. (Q33977273):
Displaying 50 items.
- Vitamin C: intravenous use by complementary and alternative medicine practitioners and adverse effects (Q21136326) (← links)
- Antiproliferative effect of ascorbic acid is associated with the inhibition of genes necessary to cell cycle progression (Q21143876) (← links)
- Vitamin C for treating atrial fibrillation (Q24186942) (← links)
- Vitamin C for preventing and treating pneumonia (Q24200502) (← links)
- Vitamin C for preventing and treating the common cold (Q24201652) (← links)
- Vitamin C for preventing and treating tetanus (Q24202470) (← links)
- Vitamin C for preventing and treating tetanus (Q24243060) (← links)
- Vitamin C for preventing and treating pneumonia (Q24243212) (← links)
- Vitamin C for preventing and treating the common cold (Q24244256) (← links)
- Vitamin C for preventing and treating tetanus (Q24244881) (← links)
- Pharmacologic ascorbic acid concentrations selectively kill cancer cells: action as a pro-drug to deliver hydrogen peroxide to tissues (Q24531307) (← links)
- Intravenously administered vitamin C as cancer therapy: three cases (Q24540524) (← links)
- Pharmacologic doses of ascorbate act as a prooxidant and decrease growth of aggressive tumor xenografts in mice (Q24644317) (← links)
- A 12 week, open label, phase I/IIa study using apatone for the treatment of prostate cancer patients who have failed standard therapy (Q24644493) (← links)
- Changes of terminal cancer patients' health-related quality of life after high dose vitamin C administration (Q24648673) (← links)
- Vitamin C: update on physiology and pharmacology (Q24654791) (← links)
- Ascorbate in pharmacologic concentrations selectively generates ascorbate radical and hydrogen peroxide in extracellular fluid in vivo (Q24678072) (← links)
- Nutrition and cancer: a review of the evidence for an anti-cancer diet (Q24792822) (← links)
- Misleading information on the properties of vitamin C (Q24816427) (← links)
- Narrow scope of vitamin C review (Q24816443) (← links)
- Vitamin C for treating atrial fibrillation (Q26471829) (← links)
- Treatment of Pancreatic Cancer with Pharmacological Ascorbate (Q26800853) (← links)
- Ascorbate as a co-factor for fe- and 2-oxoglutarate dependent dioxygenases: physiological activity in tumor growth and progression (Q26822640) (← links)
- Regulation of vitamin C homeostasis during deficiency (Q26992736) (← links)
- Radiographic contrast-media-induced acute kidney injury: pathophysiology and prophylactic strategies (Q27021421) (← links)
- Increasing Superoxide Production and the Labile Iron Pool in Tumor Cells may Sensitize Them to Extracellular Ascorbate (Q27021794) (← links)
- Can supplementation with vitamin C and E alter physiological adaptations to strength training? (Q28391237) (← links)
- Ascorbic acid and a cytostatic inhibitor of glycolysis synergistically induce apoptosis in non-small cell lung cancer cells (Q28533798) (← links)
- Increased ventilatory response to carbon dioxide in COPD patients following vitamin C administration (Q28596757) (← links)
- Postprandial Metabolism of Macronutrients and Cardiometabolic Risk: Recent Developments, Emerging Concepts, and Future Directions. (Q30362026) (← links)
- Mechanisms of ascorbate-induced cytotoxicity in pancreatic cancer (Q30492805) (← links)
- Intravenous vitamin C in the treatment of post-laser hyperpigmentation for melasma: a short report (Q33373384) (← links)
- The role of vitamin C in the treatment of pain: new insights (Q33564426) (← links)
- Vitamin C transporter Slc23a1 links renal reabsorption, vitamin C tissue accumulation, and perinatal survival in mice (Q33761086) (← links)
- Effect of disodium EDTA chelation regimen on cardiovascular events in patients with previous myocardial infarction: the TACT randomized trial (Q33792060) (← links)
- Intravenous vitamin C administration reduces fatigue in office workers: a double-blind randomized controlled trial (Q34030321) (← links)
- Effect of Vitamin C Supplementation on C-reactive Protein Levels in Patients Undergoing Hemodialysis: A Randomized, Double Blind, Placebo-Controlled Study. (Q34040520) (← links)
- Proteomic analysis of tumor tissue in CT-26 implanted BALB/C mouse after treatment with ascorbic acid. (Q34090496) (← links)
- Phase I evaluation of intravenous ascorbic acid in combination with gemcitabine and erlotinib in patients with metastatic pancreatic cancer (Q34137350) (← links)
- Antioxidants and Other Micronutrients in Complementary Oncology (Q34140158) (← links)
- The effect of intravenous vitamin C on cancer- and chemotherapy-related fatigue and quality of life (Q34349450) (← links)
- Review of high-dose intravenous vitamin C as an anticancer agent (Q34406887) (← links)
- Is there a role for oral or intravenous ascorbate (vitamin C) in treating patients with cancer? A systematic review (Q34458788) (← links)
- Should patients undergoing chemotherapy and radiotherapy be prescribed antioxidants? (Q34564943) (← links)
- Vitamin C and cancer revisited (Q34595214) (← links)
- Oxalic acid excretion after intravenous ascorbic acid administration (Q34603325) (← links)
- Ascorbic acid inhibits antitumor activity of bortezomib in vivo (Q34606574) (← links)
- High concentrations of L-ascorbic acid specifically inhibit the growth of human leukemic cells via downregulation of HIF-1α transcription. (Q34693392) (← links)
- Intravenous ascorbic acid to prevent and treat cancer-associated sepsis? (Q34704572) (← links)
- Vitamin C: a concentration-function approach yields pharmacology and therapeutic discoveries (Q34729895) (← links)